Long-term monitoring of the effects of thymoxamine hydrochloride tablets in the management of patients with Raynaud's disease

References

• Aylward M. Hexopal in Raynaud's disease. J. Int. Med. Res 1979; 7: 484–4911. Aylward M. Hexopal in Raynaud's disease. J. Int. Med. Res 1979; 7: 484–491
   PubMedGoogle Scholar
• Aylward M., Maddock J., Wheeldon R., Parker R. J. A study of the influence of various antirheumatic drug regimens on serum acute phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis. Rheumatol. Rehabil 1975; 14: 101–1142. Aylward M., Maddock J., Wheeldon R., Parker R. J. A study of the influence of various antirheumatic drug regimens on serum acute phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis. Rheumatol. Rehabil 1975; 14: 101–114
   PubMedGoogle Scholar
• Birmingham A. X., Szolczani J. Competitive blockade of adrenergic a-receptors and histamine receptors by thymoxamine. J. Pharm. Pharmacol 1965; 17: 449–4593. Birmingham A. X., Szolczani J. Competitive blockade of adrenergic a-receptors and histamine receptors by thymoxamine. J. Pharm. Pharmacol 1965; 17: 449–459
   PubMed Web of Science ®Google Scholar
• Born G. V. R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–9294. Born G. V. R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–929
   PubMed Web of Science ®Google Scholar
• Crockson R. A., Crockson A. P. Relationship of the ESR to viscosity and plasma proteins in rheumatoid arthritis. Ann. Rheum. Dis 1974; 33: 53–565. Crockson R. A., Crockson A. P. Relationship of the ESR to viscosity and plasma proteins in rheumatoid arthritis. Ann. Rheum. Dis 1974; 33: 53–56
   PubMed Web of Science ®Google Scholar
• Davies D. E. D., Dewland P. M., Dinsdale J. R. M., Maddock J., Aylward M. Controlled trial of effects of thymoxamine on microcirculatory cold sensitivity and digital artery patency in Raynaud's disease. In press. 19826. Davies D. E. D., Dewland P. M., Dinsdale J. R. M., Maddock J., Aylward M. Controlled trial of effects of thymoxamine on microcirculatory cold sensitivity and digital artery patency in Raynaud's disease. In press. 1982
   Google Scholar
• Dewland P. M., Davies D. E., Protheroe D. A., Lewis P. A., Aylward M., Maddock J. Thymoxamine on blood flow in health and in Raynaud's Disease. “Abstracts of World Conference on Clinical Pharmacology and Therapeutics”, P. Turner, C. Padgham. Macmillan, London 1980; 5157. Dewland P. M., Davies D. E., Protheroe D. A., Lewis P. A., Aylward M., Maddock J. Thymoxamine on blood flow in health and in Raynaud's Disease. “Abstracts of World Conference on Clinical Pharmacology and Therapeutics”, P. Turner, C. Padgham. Macmillan, London 1980; 515
   Google Scholar
• Fagerhol M. K., Abildgaard U. Immunological studies on human antithrombin III. Influence of age, sex and use of oral contraceptives on serum concentrations. Scand. J. Haematol 1970; 7: 10–178. Fagerhol M. K., Abildgaard U. Immunological studies on human antithrombin III. Influence of age, sex and use of oral contraceptives on serum concentrations. Scand. J. Haematol 1970; 7: 10–17
   PubMedGoogle Scholar
• Haavik-Nilsen K. Effects of naftidrofuryl on microcirculatory cold sensitivity in Raynaud's phenomenon. Br. Med. J 1979; 1: 20–219. Haavik-Nilsen K. Effects of naftidrofuryl on microcirculatory cold sensitivity in Raynaud's phenomenon. Br. Med. J 1979; 1: 20–21
   Web of Science ®Google Scholar
• Jamieson G. G., Ludbrook J., Wilson A. Cold hypersensitivity in Raynauds phenomenon. Circulation 1971; 44: 254–26410. Jamieson G. G., Ludbrook J., Wilson A. Cold hypersensitivity in Raynauds phenomenon. Circulation 1971; 44: 254–264
   PubMed Web of Science ®Google Scholar
• Johnson A. J., Kline D. L., Alkjaersig N. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems. Thromb. Diath. Haemorrh 1969; 21: 259–27211. Johnson A. J., Kline D. L., Alkjaersig N. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems. Thromb. Diath. Haemorrh 1969; 21: 259–272
   PubMedGoogle Scholar
• Kent S. J. S., Thomas M. L., Browse N. L. Assessment of digital artery patency by arteriography. J. Cardiovasc. Surg 1976; 17: 72–7612. Kent S. J. S., Thomas M. L., Browse N. L. Assessment of digital artery patency by arteriography. J. Cardiovasc. Surg 1976; 17: 72–76
   PubMedGoogle Scholar
• Lewis T. Experiments relating to the peripheral mechanism involved in spasmodic arrest of the circulation in the fingers, a variety of Raynaud's disease. Heart 1930; 15: 329–35013. Lewis T. Experiments relating to the peripheral mechanism involved in spasmodic arrest of the circulation in the fingers, a variety of Raynaud's disease. Heart 1930; 15: 329–350
   Google Scholar
• Mann H. B., Whitney D. R. On a test of whether one or two random variables is statistically larger than the other. Ann. Math. Statistics 1947; 18: 52–6014. Mann H. B., Whitney D. R. On a test of whether one or two random variables is statistically larger than the other. Ann. Math. Statistics 1947; 18: 52–60
   Google Scholar
• Marston A. Drugs and peripheral blood flow. Prescribers J 1981; 21: 233–23615. Marston A. Drugs and peripheral blood flow. Prescribers J 1981; 21: 233–236
   Google Scholar
• Merskey C., Kleimer G. J., Johnson A. J. Quantitation of fibrinogen degradation products in human blood. Blood 1966; 28: 1–416. Merskey C., Kleimer G. J., Johnson A. J. Quantitation of fibrinogen degradation products in human blood. Blood 1966; 28: 1–4
   PubMed Web of Science ®Google Scholar
• O'Reilly M. J. G., Talpos G., Roberts V. C., White J. M., Cotton L. T. Controlled trial of plasma exchange in treatment of Raynaud's syndrome. Br. Med. J 1979; 1: 1113–111517. O'Reilly M. J. G., Talpos G., Roberts V. C., White J. M., Cotton L. T. Controlled trial of plasma exchange in treatment of Raynaud's syndrome. Br. Med. J 1979; 1: 1113–1115
   PubMed Web of Science ®Google Scholar
• Poller L., Thomson J. M., Sear C. H. J. The partial thomboplastin (cephalin) time. J. Clin. Pathol 1972; 25: 1038–104118. Poller L., Thomson J. M., Sear C. H. J. The partial thomboplastin (cephalin) time. J. Clin. Pathol 1972; 25: 1038–1041
   PubMed Web of Science ®Google Scholar
• Ramsay C. The value of intravenous thymoxamine as a cutaneous vasodilator. J. Clin. Pharmacol 1969; 9: 239–24219. Ramsay C. The value of intravenous thymoxamine as a cutaneous vasodilator. J. Clin. Pharmacol 1969; 9: 239–242
   Web of Science ®Google Scholar
• Roddie I. C., Wallace W. F. M. Methods for the assessment of drugs on the arterial system in man. Br. J. Clin. Pharmacol 1979; 7: 317–32420. Roddie I. C., Wallace W. F. M. Methods for the assessment of drugs on the arterial system in man. Br. J. Clin. Pharmacol 1979; 7: 317–324
   PubMed Web of Science ®Google Scholar
• Scheffe H. “The Analysis of Variance”. Wiley, New York 1959; 112–11921. Scheffe H. “The Analysis of Variance”. Wiley, New York 1959; 112–119
   Google Scholar
• Shepherd J. T. “Physiology of the Circulation in Human Limbs in Health and Disease”. Saunders, Philadelphia 196322. Shepherd J. T. “Physiology of the Circulation in Human Limbs in Health and Disease”. Saunders, Philadelphia 1963
   Google Scholar
• Strandness D. E., Sumner D. S. “Haemodynamics for Surgeons”. Grune & Stratton, New York 197523. Strandness D. E., Sumner D. S. “Haemodynamics for Surgeons”. Grune & Stratton, New York 1975
   Google Scholar